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Aim: To analyze randomized controlled trials (RCTs) on pulmonary rehabilitation (PR) to 
determine whether the patients who complete PR form a representative subset of the chronic 
obstructive pulmonary disease (COPD) target population and to discuss what impact this may 
have for the generalizability and implementation of PR in practice.
Material and methods: A review of 26 RCTs included in a Cochrane Review 2007. We analyzed 
the selection at three different levels: 1) sampling; 2) inclusion and exclusion; 3) and dropout.
Results: Of 26 studies only 3 (12%) described the sampling as the number of patients contacted. 
In these studies 28% completed PR. In all we found, that 75% of the patients suitable for PR 
programs were omitted due to sampling exclusion and dropout. Most of the study populations 
are not representative of the target population.
Conclusion: The RCTs selected for the Cochrane review gave sparse information about the 
sampling procedure. The demand for high internal validity in studies on PR reduced their external 
validity. The patients completing PR programs in RCTs were not drawn from a representative 
subset of the target population. The ability to draw conclusions relevant to clinical practice from 
the results of the RCTs on PR is impaired.
Keywords: COPD, rehabilitation, selection, dropout, external validity
Introduction
The primary goal of pulmonary rehabilitation (PR) is to restore the patients to the 
highest possible level of independent function, and the target population are patients 
with stable chronic obstructive pulmonary disease (COPD).1–6 PR evidently seems to 
benefit the patients in terms of quality of life, functional capacity, symptom relief, and 
reductions in exacerbation of the condition and in the number of days in hospital. PR 
is therefore recommended in all influential guidelines based on grade A.2,3,6,7
The concept of PR rests on a large number of randomized controlled trials (RCTs) 
and is defined as “an evidence-based, multidisciplinary, and comprehensive interven-
tion for patients with chronic respiratory diseases who are symptomatic, and often have 
decreased daily life activities. Integrated into the individualized treatment of the patient, 
pulmonary rehabilitation is designed to reduce symptoms, optimize functional status, 
increase participation, and reduce health care costs through stabilizing or reversing 
systemic manifestations of the disease”.4 Patients must accordingly exercise with a 
certain intensity, duration and frequency, and they must be well-informed about their 
disease through interventions such as patient education, together with being taught Clinical Epidemiology 2010:2 74
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self-help and coping strategies. In addition, the patients must 
perform medication and breathing techniques correctly, and 
they must stop smoking.
Since the 1980s, at least 600 controlled trials on COPD 
and rehabilitation have been published. During this period, 
the PR concept has expanded, specific components have 
been developed, and techniques have steadily become more 
comprehensive and sophisticated.8–10
PR is recommended in Denmark and it has therefore 
been suggested that any COPD patient who is registered with 
severe dyspnea measured with Medical Research Council 
Dyspnea Scale MRC11grade 3 should be offered PR.12 How-
ever, a report from the Danish National Indicator Project13 
documents that approximately only 60% (CI:59–62) of 
patients registered with MRC grade 3 are offered rehabili-
tation. Also there is no documentation of number of patients 
that complete a program or the effects of the rehabilitation. 
This shows that we do not know who actually completes PR 
nor who will benefit from it, when it is to be implemented 
in clinical practice.12
In general, COPD patients have extensive rehabilitation 
needs because their disease imposes major restrictions on 
their everyday life;3,4,6 however, poor adherence is common 
in daily practice as some patients fail to attend programs and 
others drop out.3,4,6,7,14–18 Our experience is that in order to 
optimize the resources used on PR, patients are selected so 
that those who are deemed to have the ability and motivation 
to complete a PR program are more likely to be chosen for 
participation than patients with poor motivation. This may 
entail understandable, but ethically inappropriate inequality 
in access to health care.
The effect of PR is well documented in RCTs and its 
rationale can therefore hardly be questioned as RCTs are 
considered to represent the most scientifically rigorous method 
of hypothesis testing in order to provide the best evidence.7,19 
RCTs must satisfy strict quality criteria and explicit standards 
regarding patient selection. However, RCTs on PR often fail to 
adequately discuss their external validity, ie, the ability to “pro-
duce unbiased inferences regarding the target population”.19 
We may therefore justifiably question whether the reported 
effects can indeed be generalized to the target population.
Selection in RCTs may take place at three different levels: 
1) sampling; 2) inclusion and exclusion; and 3) dropout. At 
the sampling level, a number of COPD patients are selected 
among all subjects within a particular population.19 The 
selection criteria used prior to randomization, ie, when some 
patients are contacted for screening, and others are not, need 
to be explicit. At the inclusion/exclusion level, criteria are 
defined to establish the study population and to homogenize 
the intervention group and the control group. This level faces 
the risk that the patients included differ in certain aspects 
from those who are not included.
At these first two levels, selection is a matter of the 
investigator’s choice and ideally, information about all 
patients who are not included must be registered in order to 
optimize the external validity.
At the third and final level, dropout may contribute to a 
weakening of the internal validity; ie, dropout may cause, 
that the observed differences between the compared groups, 
may not be attributed only to the hypothesized effect under 
investigation.19
The challenges involved in achieving high internal and 
external validity makes selection of patients for PR a per-
tinent issue. Patients, clinicians and decision-makers need 
clear messages about the evidence of PR to accept its wide-
spread application and to ensure that scarce resources can 
be used to good effect. Dropout is usually well-described in 
RCTs on PR, but information on selection performed during 
sampling, ie, before randomization, remains sparse. There 
would therefore seem to be some room for strengthening the 
discussion of the validity of RCTs in general, and of their 
external validity in particular by examining pre-randomiza-
tion selection issues at greater depth.
The aim of the present study is to analyze RCTs on PR 
to determine whether the patients who complete PR form a 
representative subset of the COPD target population and to 
discuss what impact this may have for the generalizability 
and implementation of PR in practice.
Material and methods
A literature review of the RCTs originally included in the 
Cochrane review7 published in 2007 endevoured “to establish 
the influence and the effect size of pulmonary rehabilitation 
on health related quality of life, functional capacity in patients 
with COPD”. The review stated that “Rehabilitation relieves 
dyspnea and fatigue, improves emotional function and 
enhances patients’ sense of control over their condition”. This 
review was chosen for this present analysis because it strived 
to comprehensively identify and synthesize all the literature 
on PR, and it is in general, well-reputed and often cited.
The Cochrane review included a total of 31 RCTs of 
which 26 full-text English language versions were examined. 
Five studies were not examined; three studies were only 
available as English abstracts as the articles were published 
in Spanish,20 French,21 and Chinese.22 Boxall23 was not used 
in the form, ie, congress abstract, in which it was used in the Clinical Epidemiology 2010:2 75
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Cochrane review, it was instead published as an article in 
2006.24 Chlumsky 200125 was not found. Casaburi26 was not 
included in this analysis as its focus on testosterone supple-
mentation was deemed irrelevant to the present purpose.
The 26 RCTs were analyzed with regard to their descrip-
tion of sampling, inclusion and exclusion criteria, and dropout 
illustrated in Figure 1.
Correlation analyses were performed to examine possible 
associations between selection criteria, disease events, the 
rehabilitation program, and the number of patients left out.
Results
The results of the analysis are described in three sections 
corresponding to the three levels: 1. sampling, 2. inclusion 
and exclusion, and 3. dropout.
1. Sampling
Only three (12%) out of 26 studies described the number of 
patients contacted (Table 1).27–29 In these studies, a total of 
322 patients were contacted and out of those 151 (47%) were 
left out without being screened.
These three studies did not differ from the other 
23 studies18,24,30–50 in relation to the number of patients 
randomized, inclusion or exclusion criteria, dropout, or 
lung function.
Details regarding the circumstances under which the 
studies were carried out revealed that Jones and colleagues28 
searched computerized records to identify regular attenders 
at their clinic. Bendstrup and colleagues27 invited patients 
who were chosen from hospital records, however, the total 
number of relevant records was not described. Ringbaek and 
colleagues29 contacted the patients with moderate COPD, 
who were recruited from an outpatient clinic during a   
six-month period, however, the total number of relevant 
records was not described.
In brief, the size of the total COPD population, which is 
relevant for the external validity of the studies reviewed, is 
largely unknown and only a few studies were explicit about 
the characteristics of the populations from which the study 
populations were drawn. Nearly half of the patients contacted 
were not offered screening, and only one third of the patients 
contacted actually completed the PR program.
“Unknown total COPD population”
1st level
2nd level
3rd level
“Patients contacted”
“Patients screened”
Exclusion
Dropouts
Randomization
Completers
Inclusion
Figure 1 The different levels of selection.Clinical Epidemiology 2010:2 76
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2. inclusion and exclusion
Information regarding the number of patients screened and 
the number of patients de-selected is mainly due to inclu-
sion and exclusion criteria, which was stated in the three 
above-mentioned studies (Table 1) and in five other studies 
(Table 2).18,33,36,39,40
In all, eight studies screened a total of 1,040 patients of 
whom 406 (39%) were de-selected before randomization, and 
the de-selection percentage ranged from 8%–64%.
Reasons for leaving out some patients were, eg, those who 
lived too far away or whose social circumstances affected 
their ability to complete the program.18 Only patients who 
had the ability to travel independently to a physiotherapy 
practice and the motivation to improve self-care were chosen 
for participation.33
A study recruited patients by means of announcements 
and some were screened over the telephone, however, neither 
the exact number of responders nor the number of telephone 
screenings were reported.36
In general only stable patients were randomized. The 
majority of the studies (18 out of 26) were not explicit regarding 
the number of patients deselected due to exclusion criteria.
The correlation between the proportion of patients left 
out from screening to randomization and the total number of 
patients screened showed a correlation, the Spearman’s correla-
tion coefficient (0.643) tended to be significant (P = 0.086).
This indicates that the higher the number of patients 
screened the stricter the screening procedures were. There 
was no statistically significant correlation between the num-
ber of patients left out from screening to randomization and 
the number of diagnosis-specific inclusion and exclusion 
criteria (P = 0.9) nor the number of non-disease-specific 
inclusion and exclusion criteria (P = 0.3).
The exclusion criteria varied. Up to 6 pulmonary disease-
specific exclusion criteria were used in the studies, eg, lung 
function, dyspnea, arterial blood gases, oxygen saturation, 
and smoking. One to seven non-pulmonary disease-specific 
criteria were used in the studies, eg, ischemic heart disease, 
cognitive impairment, musculoskeletal disorders, social cir-
cumstances, transport difficulties, or language barriers.18,33
To summarize, the wide range (6%–64%) of patients left 
out from screening to randomization could not be explained 
by the number of explicit exclusion criteria. The analysis 
showed that a total of 8 (31%)18,27–29,33,36,39,40 of the 26 articles 
documented the sampling procedure from screening to ran-
domization. The rate of patients completing a PR program 
out of the total number of patients screened ranged from 
32% to 100%.
3. Dropout
Dropout was described in all 26 studies (Table 3).18,24,27–34, 
36–46,48–52 Dropout ranged from 0% to 36% in the interven-
tion groups (mean = 17[CI: 12–22])) and from 0% to 54% 
in the control groups (mean = 15 [CI:9–22]). We found 
no differences in dropout between the intervention groups 
and the control groups (P = 0.4), and the correlation analy-
sis showed a statistically significant, positive correlation 
(Spearman 0.72, P = 0.00).
The reasons for dropout can roughly be divided into 
two categories: “disease-related reasons,” eg, exacerba-
tions, illness and death, and “other reasons”, eg, lack of 
time, motivation or cooperation (ie, patients did not want to 
participate, travelling difficulties, the PR-programme was to 
hard). In 17 out of 26 studies, “other reasons” for dropout 
were described.
None of the studies discussed the possibility that dropout 
may cause misclassification,53 or the direction of possibly 
biased estimates.
Altogether we found, when the size of the unknown 
total population was ignored, that on average, three quarters 
of the patients most likely suitable for PR seemed to have 
been de-selected, probably in a biased way, due to sampling, 
exclusion criteria, and dropout. None of the studies discussed 
generalizability and applicability.
Discussion
The present study aimed to determine whether the patients 
who complete PR form a representative subset of the target 
population. This study details aspects of patient selection 
for RCTs based on the sampling procedures described in 
the RCTs on PR included in a Cochrane review. The main 
result of the study is that most RCT study populations are 
not sufficiently representative of the COPD target population. 
This seriously affects the external validity of these studies 
and may inhibit the implementation and effects of PR in 
clinical practice.
The discussion is divided into four parts. The first part con-
cerns the target population and the following three parts discuss 
the different levels of selection as illustrated in Figure 1.
The target population
For the sake of generalizability the study population must 
be drawn from a representative subset of the target popula-
tion,53 which, for PR, would comprise patients diagnosed 
with stable COPD. However, the target population is not 
easily determined as the COPD prevalence is generally 
difficult to estimate.54–56 Firstly, population-based estimates Clinical Epidemiology 2010:2 78
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Table 3 Studies were only the number of patients randomized were described, number of exclusions criteria and dropout   
(17/26 studies)
Ref  
number 
Study/aim 
 
Randomized/ 
completed (%) 
Exclusion disease- 
specific/others 
Dropout (%)  
(Intervention/  
control %)
Reasons dropout  
 
43 McGavin 1977  
Evaluate a training  
sheme carried out  
by the patients  
unsupervised at home
28/24 (86) 3/4 4/28 (14) (29/0) lack of euthusiasm (2) 
depressive (1),  
death (1)
35 Cockcroft 1981  
Evaluate the effects  
of exercise training  
in men with chronic  
respiratory disability
39 /34 (87) 1/2 5/39 (13) (5/20) deterioration in  
condition (2) stroke (1)  
abroad (1)  
domestic problems (1)
31 Booker 1984  
Longterm rCT  
to investigate the  
subjective and objective  
effects of progressive  
exercise training in  
patients with chronic  
airflow limitation
128/102 (80) 1/1 26/128 (20) (23/15) no reasons described
32 Busch 1988  
Effects of a 18 weeks  
home exercise program  
on physical work capacity  
and dyspnea
20/14 (70) 1/3 6/20 (30) (30/30) death (1),  
exercising of own  
volition (2),  
did not perform  
exercise regularly (3)
42 Lake 1990  
Evaluate the benefit  
of upper-limb exercise  
training alone and in  
combination with  
walking training
28/26 (93) 4/7 2/28 (7) (7/7) infection (1)  
cerebral attack (1)
45 Simpson 1992  
Determine whether  
specific muscle training  
techniques are helpful
34/28 (82) 2/3 6/34 (18) (18/17) infection (1),  
change in treatment (2) 
unknown reasons (3)
49 weiner 1992  
Effect of specific  
inspiratory muscle  
training combined  
with exercise reconditionning  
for six months
36/36 (100) 1/3 none
44 reardon 1994  
Evaluate the effect  
of outpatient pulmonary  
rehabilitation on dyspnea
20/20 (100) 3/1 none
50 wijkstra 1994  
investigate the effect  
of home rehabilitation  
programme on QoL and  
exercise tolerance
45/43 (96) 4/4 2/45 (4) (7/0) cerebral tumor (1),  
arthrosis (1)
34 Clark 1996  
investigate physiological  
effects of a 12 week  
programme of conditioning  
of peripheral muscle
48/48 (100) 1/0 none
(Continued)Clinical Epidemiology 2010:2 80
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Table 3 (Continued)
Ref  
number 
Study/aim 
 
Randomized/ 
completed (%) 
Exclusion disease- 
specific/others 
Dropout (%)  
(Intervention/ 
Control %)
Reasons dropout 
 
52 Strijbos 1996  
Effects of a 12 weeks  
outpatient pulmonary  
rehabilitation compared  
with home-based program
50/45 (90) 6/3 5/50 (10) (20/7) lack of motivation (2) 
death (2) cancer (1)
37 Engstrøm 1999  
To examine long-term  
effects of outpatients  
rehabilitation
55/ 50 (91) 5/3 5/55 (9) (7/11) death (3),  
heart disease (1),  
did not complete (1)
30 Behnke 2000  
Examine home-based  
walking training
46/30 (65) 2/3 16/46 (35) (34/34) death (2), 
exacerbation (4),  
lack of motivation (6), 
unrelated diseases (4)
48 Troosters 2000  
investigate short- and long-term 
effects of 6 months programme
62/100 (62) 2/5 38/100 (38) (32/44) refused follow-up (33) 
death (5)
41 Hernandez 2000  
investigate the effectiveness  
of a home-based program  
of exercise training
60/37 (62) 4/6 23/6 (38) (33/43) (lack of cooperation (13), 
exacerbation (8),  
cerebral accident (1) 
cancer(1)
38 Finnity 2001  
Assess the effectiveness  
of outpatient-based rP
100/55 (65) 3/7  45/100 (45) (36/54) failed to attend (27),  
failed to continue (18) 
reasons not described
46 Singh 2003  
Evaluate the effect  
of domiciliary Pr
40/40 (100) 6/4 none
23 
 
 
 
Boxall 2003/2005  
Evaluate a 12 week  
home-based Pr 
 
60/46 (77) 
 
 
 
2/3 
 
 
 
14/60 (23) (23/23) 
 
 
 
hip fracture (1)  
exacerbation (1),  
exercises to hard (3)  
cancer (1), death (1)  
reasons not described (7)
of COPD prevalence are complicated by the variety of 
tools and definitions used to describe COPD.56 Secondly, 
COPD terminology is inconsistent and widely accepted 
diagnostic standards are lacking, therefore COPD coding is 
insufficient and COPD data often inaccurate.54 Thirdly, the 
method by which prevalence is estimated (expert opinion, 
patient reporting, symptom reporting or measurement by 
spirometry) influences the reported prevalence estimates.55 
Furthermore patients who participate in RCTs on PR are 
selected among patients already in clinical practice, eg, 
clinic, hospital or by GP, and not amongst patients identified 
from prevalence studies. For these reasons the exact target 
population in RCTs remains more or less unknown. None 
of the studies in the Cochrane review discussed whether the 
study population was a representative subset of the target 
population.
Pre-randomization selection
Most studies failed to describe which patient were selected 
and those who were not; so information is lacking on 
the number of patients left out and their characteristics. 
Only three (12%) of the included studies were explicit 
about who were contacted.27–29 We have estimated that 
almost half (47%) of the patients were left out before 
screening.
Of particular concern is that none of the studies were 
explicit about the selection of cases and the bias this may 
cause. We therefore cannot be sure that the study popula-
tions were representative subsets of the target populations 
studied in relation to the effect of PR. This obviously leaves 
some severe difficulties in generalizing the findings, both 
in terms of capability to complete, and on the effects of 
participating in PR.Clinical Epidemiology 2010:2 81
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Representativeness should be ensured by randomly 
selecting the study population so that, ideally, all patients 
relevant for a study would have the same chance of enrol-
ment. This requires that the investigator controls the target 
population and pays attention to any difference between the 
patients who were selected and those who were not.53 Dur-
ing this selection process, patients who, eg, were deemed 
not to have the ability to complete the programs, who lived 
too far away, or who had difficult social circumstances18 
would be at risk of being left out. Such left out patients 
would likely differ from those who were included in rela-
tion to important variables, eg, incriminating psychosocial 
situation.
inclusion and exclusion criteria
Only in 8 of the 26 studies was number of patients deselected 
during screening explicit (Tables 1 and 2).18,27–29,33,36,39,40 
Approximately one third of the patients were left out. No 
correlation was found between the number of patients lost 
from screening to randomization and the number of inclu-
sion and exclusion criteria; therefore the number of patients 
left out cannot be directly explained with reference to these 
criteria. The study populations must be pathophysiologi-
cally uniform to optimize study power and therefore strict 
exclusions criteria must be used. This premise is obvious 
but there might still be a risk that nonexplicit criteria are 
responsible for the number of patients left out. This compli-
cates the implementation of PR, as it is not known whether 
the findings can be applied to the population which is to 
benefit from PR.
We assume that the reviewed RCTs a priori recruited the 
most motivated patients to maximize completion and compli-
ance with the intervention.18 Our analysis revealed that those 
who declined the intervention stated a variety of reasons, eg, 
skepticism as to their ability to attend and to adhere to study 
requirements, problems of transportation. Including smokers 
in PR programs is often conditional on their participation in 
a smoking cessation program, and smokers are therefore less 
likely to participate.17
In summary there is a risk that patients selected for par-
ticipation differed from the deselected patients in relation to 
social factors, co-morbidity and their general health status. 
The selection may not have been truly random, and therefore 
skewed by explicit as well as non-explicit choices. Implicit 
criteria hinder the possibility that effects, as documented in 
RCTs, are to be reached, when PR is implemented in the target 
population.
Dropout
In accordance with the Helsinki declaration, dropout was 
described in all 26 studies. Some dropout should be expected 
in PR due to the natural history of COPD and therefore selec-
tion is usually carried out to reduce dropout.
Our analyses showed huge variation in dropout rates 
(ranging from 0% to approximately 50%). Moreover, a strong 
positive correlation was observed between dropout in the 
intervention groups and in the control groups, which means 
that only a small part of the dropout can be explained by the 
intervention. Contrary to expectation, the number of explicit 
exclusion criteria and the duration of the intervention did not 
explain the wide variation in dropout.
The patients’ own views and experiences may influence 
dropout, (eg, if the patients think that the programs are either, 
too hard, too demanding, too difficult or too easy, unlikely to 
be helpful, and a waste of time), in which case they will be 
more likely to drop out. If the patients do not feel comfort-
able or unsafe and not at ease with the health professionals, 
or with the other patients, they may also tend to drop out. 
Whereas the support of family and peers may enhance patient 
adherence. Besides, the patients’ perception of their illness 
and its management may have an influence.17,57,58 If the reha-
bilitation program makes common sense, in relation to the 
patients’ personal beliefs about their illness, completion may 
be more likely to be achieved. Empathic understanding and 
the practitioner relationship may also have some impact.
In general, the differences between completers and 
dropouts are unknown and it is difficult to determine, how 
dropout has affected the results.
in summary
The question raised in this study is whether the findings of 
the RCTs and the recommendations that emanate from the 
Cochrane review7 apply to the entire PR target population. Our 
analyses show uncertainty regarding the representativeness of 
the COPD patients who completed the PR programs.
If PR, based on RCTs, is only applicable to a limited sub-
set of the target population, it may lead to social inequality. 
Patients with severe disease may be too physically impaired 
to actively participate in and benefit from a program. Patients 
with a mild disease and minimal limitations may not benefit 
from the program because of a lack in perceived need and 
motivation.59 Patients at different stages of COPD have 
different needs, as the management of mild and moderate 
COPD involves the avoidance of risk factors in order to 
prevent the progression of the disease and pharmacotherapy Clinical Epidemiology 2010:2 82
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to control symptoms. Severe and very severe COPD require 
integration of several different disciplines, a variety of treat-
ment approaches, and continued patient support.1
PR is a recommended standard of care that encourages 
patients to undertake their own health care and to become 
less dependent on health professionals and expensive medical 
resources. PR focuses on reducing disability from the disease 
despite the severity. For these reasons, it is problematic that 
the evidence for PR rests on studies where the study popula-
tion is not representative, eg, that COPD patients with co-
morbidity and different social circumstances are excluded.
Conclusion
In conclusion, the RCTs selected for the Cochrane review 
comprised information about the included patients and drop-
outs, though not about the sampling procedure. The internal 
validity was assessed in order to examine the relationship 
between the intervention and the treatment effect. The 
demand for high internal validity in studies of the effect of 
PR reduced their external validity, which was not assessed.
The patients completing PR programs in RCTs were not 
drawn from a representative subset of the target population. 
A number of criteria which were not explicit were used dur-
ing the sampling. The studies did not meet the ideal demands 
for representativeness, which should be obtained by random 
sampling, and for equality of opportunity to participate for 
all patients. This impairs our ability to draw general conclu-
sions relevant to clinical practice from the results of the 
RCTs on PR.
To strengthen the external validity from studies on 
PR, there is an extensive need for explicitness in all levels 
of patient selection. Studies on PR in nonselected target 
populations drawn from prevalence studies are needed in 
order to determine the number of completers and the effects 
gained. In addition, studies focusing on potential differences 
between COPD patients who complete, drop out or de-select 
rehabilitation are relevant when discussing how PR can be 
implemented to a larger proportion of the target population.
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